View older revisions Content changed at 2021-07-25, 1400/05/03

Protocol summary

Study aim
the aim of this study is to examine the effect of intrauterine administration of GCSF in IVF cycles on the fertility rate of infertile women suffering from moderate to severe endometriosis.
Design
The sample size of this study is 66 persons who will be randomly divided into two groups of GSF injection and without intervention. Participant are allocated by computerized list
Settings and conduct
This is a single-blind clinical trial study on 66 infertile women at Arash Hospital. After allocation, the first group receives GSF injection immediately after puncture and the second group has no intervention. Clinical pregnancy is assessed by transvaginal ultrasound 3 weeks after transfer.
Participants/Inclusion and exclusion criteria
The inclusion criteria: fertility due to endometriosis, age 18-40 years, moderate to severe endometriosis Inclusion criteria: male factor infertility, evidence of a significant decrease in the ovarian reserve (FSH>11, AMH<0.5, decreased AFC), endocrine disorders (diabetes, thyroid diseases, hyperprolactinemia, hypothalamic amenorrhea, etc.), confirmed medical and immunologic diseases
Intervention groups
Intervention group: Immediately after ovarian puncture, 300µ GCSF is injected through a transcervical catheter into the uterine cavity Subjects in the control group received no intervention (blank control)
Main outcome variables
Clinical pregnancy

General information

Reason for update
Moderate and severe endometriosis were further explained.In this study, it was not possible to blind the patient
Acronym
IRCT registration information
IRCT registration number: IRCT20110731007165N7
Registration date: 2019-09-10, 1398/06/19
Registration timing: retrospective

Last update: 2021-07-25, 1400/05/03
Update count: 1
Registration date
2019-09-10, 1398/06/19
Registrant information
Name
Ladan Kashani
Name of organization / entity
Tehran University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 21 8828 1866
Email address
kashani_ladan@tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2019-01-15, 1397/10/25
Expected recruitment end date
2019-09-01, 1398/06/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of intrauterine administration of granulocyte-colony stimulating factor (GCSF) in IVF cycles on the fertility rate of infertile women suffering from moderate to severe endometriosis
Public title
Effect of intrauterine administration of granulocyte-colony stimulating factor (GCSF) in IVF cycles on the fertility rate of infertile women
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
First time IVF due to infertility Moderate to severe endometriosis (according to laparoscopic criteria, moderate endometriosis was defined as Adhesion affecting Fallopian tubes or ovaries, and severe endometriosis was defined as the involvement of Fallopian tubes, ovaries, and cul-de-sac) Age 18-40 years Fertility due to endometriosis Moderate -to –severe endometriosis was characterized by endometrial glands and stroma at least 5 mm beneath the peritoneum or an ovarian endometriotic cyst (endometrioma)
Exclusion criteria:
Male factor infertility. Evidence of a significant decrease in the ovarian reserve (FSH>11, AMH<0.5, decreased AFC), Endocrine disorders (diabetes, thyroid diseases, hyperprolactinemia, hypothalamic amenorrhea, etc.) , confirmed medical and immunologic diseases (SLE, rheumatoid arthritis, antiphospholipid syndrome, cardiovascular, liver, and renal diseases), and congenital uterine anomalies and uterine cavity disorder (bicornuate uterus, unicornuate uterus, Asherman syndrome, myoma, polyps, etc.). Donation candidates (ovum donation and surrogate utrus) were also excluded from the study
Age
From 18 years old to 40 years old
Gender
Female
Phase
3
Groups that have been masked
No information
Sample size
Target sample size: 66
Randomization (investigator's opinion)
Randomized
Randomization description
Our sample size is 66 people, with 33 people in each group.patients were allocated by simple randomization.In this method RANDBETWEEN function in the Excel program is used to generate a random number between 1 and 2. This is repeated 66 times.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Tehran University of Medical Sciences
Street address
Qods St, Keshavarz Blvd, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1417653761
Approval date
2019-01-12, 1397/10/22
Ethics committee reference number
IR.TUMS.MEDICINE.REC.1397.787

Health conditions studied

1

Description of health condition studied
Infertility
ICD-10 code
N97.8
ICD-10 code description
Female infertility of other origin

Primary outcomes

1

Description
clinical pregnancy
Timepoint
3 weeks after embryo transfer
Method of measurement
Vaginal ultrasound

Secondary outcomes

empty

Intervention groups

1

Description
Intervention: Immediately after ovarian puncture, 300µ GCSF is injected into the uterine cavity
Category
Treatment - Drugs

2

Description
Control group: no intervention
Category
N/A

Recruitment centers

1

Recruitment center
Name of recruitment center
Arash women's hospital
Full name of responsible person
Dr.Ladan Kashani
Street address
No. 162 َAlley (Abdul Majid), Shahid Baghdarnia Street (North Rashid), Shahid Bagheri Highway, Resalat Highway, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1653915981
Phone
+98 21 7788 3283
Fax
+98 21 7788 3196
Email
Kashani_ladan@tums.ac.ir
Web page address
http://arash.tums.ac.ir/

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr Sahraean
Street address
Tehran University of Medical Sciences, Keshavarz Blvd
City
Tehran
Province
Tehran
Postal code
1417653761
Phone
+98 21 8163 3698
Email
vcr@tums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr. Ladan Kashani
Position
Assistant Prof.
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Arash Hospital, Rashid Street, Tehran Pars
City
Tehran
Province
Tehran
Postal code
1653915981
Phone
+98 21 7788 3195
Fax
Email
Kashani_ladan@tums.ac.ir
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr. Ladan Kashani
Position
Assistant Prof.
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Arash Hospital, Rashid Street, Tehran Pars
City
Tehran
Province
Tehran
Postal code
1653915981
Phone
+98 21 7788 3195
Fax
Email
Kashani_ladan@tums.ac.ir
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Ladan Kashani
Position
Associate professor
Latest degree
Medical doctor
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Arash hospital, Tehranpars
City
Tehran
Province
Tehran
Postal code
1653915981
Phone
+98 21 8828 1866
Fax
+98 21 8895 2510
Email
kashani_ladan@tums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...